Please assess the completion status of the following clinical trial:

Trial Title: Effect of Oral Phloroglucin (Flospan®) as Premedication of Non-sedative Diagnostic Esophagogastroduodenoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients who perform non-sedative endoscopy for diagnosis or screening purposes.~* patients who understand and follow the directions and questionnaires of clinical trials.~* patients who have decided to voluntarily participate in this clinical trial and have agreed in writing~Exclusion Criteria:~* Patients who performed Upper GI surgery.~* Severe gastric outlet obstruction or malformations or gastroparesis~* Patients who have severe cognitive impairment~* Pregnant or lactation patients~* Patients who need to hemostasis for upper GI bleeding~* Hemodynamic unstable patients~* Above American Society of Anesthesiology classification class 4

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- Phloroglucin group (Type: EXPERIMENTAL): patients taken Phloroglucin(Flospan®)
- Normal saline placebo group (Type: PLACEBO_COMPARATOR): patients taken normal saline placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).